Because natriuretic peptides are increasingly part of the clinical definition of HF13 and are routinely measured during the diagnostic evaluation of patients with suspected HF, NT-proBNP is a strong candidate biomarker for prediction models in people without HF. Here, NPPB is linked to hydrops fetalis.